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Summary
Primary ciliary dyskinesia (PCD) is a group of hetero-
geneous disorders of unknown origin, usually inherited
as an autosomal recessive trait. Its phenotype is char-
acterized by axonemal abnormalities of respiratory cilia
and sperm tails leading to bronchiectasis and sinusitis,
which are sometimes associated with situs inversus (Kar-
tagener syndrome) and male sterility. The main ciliary
defect in PCD is an absence of dynein arms. We have
isolated the first gene involved in PCD, using a candi-
date-gene approach developed on the basis of docu-
mented abnormalities of immotile strains of Chlamy-
domonas reinhardtii, which carry axonemal ultrastruc-
tural defects reminiscent of PCD. Taking advantage of
the evolutionary conservation of genes encoding axo-
nemal proteins, we have isolated a human sequence
(DNAI1) related to IC78, a C. reinhardtii gene encoding
a dynein intermediate chain in which mutations are as-
sociated with the absence of outer dynein arms. DNAI1
is highly expressed in trachea and testis and is composed
of 20 exons located at 9p13-p21. Two loss-of-function
mutations of DNAI1 have been identified in a patient
with PCD characterized by immotile respiratory cilia
lacking outer dynein arms. In addition, we excluded
linkage between this gene and similar PCD phenotypes
in five other affected families, providing a clear dem-
onstration of locus heterogeneity. These data reveal the
critical role of DNAI1 in the development of human
axonemal structures and open up new means for iden-
tification of additional genes involved in related devel-
opmental defects.
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Introduction
Functional and ultrastructural abnormalities of respi-
ratory cilia have been described in patients with a con-
genital respiratory disease known as primary ciliary dy-
skinesia (PCD) (Afzelius 1976; Rossman et al. 1980).
PCD, previously described as “immotile cilia syndrome”
(MIM 242650), represents a heterogeneous group of ge-
netic disorders affecting 1/16,000 individuals; the PCD
phenotype is characterized by impaired mucociliary
clearance resulting from a lack of ciliary movements be-
lieved to be responsible for chronic lung, sinus, and mid-
dle ear diseases. Approximately 50% of patients with
PCD display situs inversus, which defines the Kartagener
syndrome (MIM 244400). Most male patients are in-
fertile as a result of nonmotile spermatozoa in relation
to functional and ultrastructural abnormalities of sperm
flagella (Afzelius 1985). Studies to date, however, have
failed to decipher the molecular basis of this disease.
PCD is usually transmitted as an autosomal recessive
trait. Indeed, most familial cases have been confined to
sibs; in several instances, patients were born to consan-
guineous unions; an absence of respiratory symptoms is
usually reported in the parents (Sturgess et al. 1986).
However, other inheritance patterns (i.e., autosomal
dominant and X-linked transmission of the disease phe-
notype) have seldom been reported (Narayan et al.
1994), thereby suggesting genetic heterogeneity in this
condition. This hypothesis is further supported by the
various functional and ultrastructural abnormalities of
respiratory cilia documented in patients with PCD (Chao
et al. 1982).
The main ciliary defect found in PCD is an absence
of dynein arms, affecting almost all cilia (Afzelius 1985).
Dyneins consist of a large family of proteins involved in
many types of microtubule-dependent cell motility in
both lower and higher eukaryotes. Two major classes of
dyneins have been described: cytoplasmic and axonemal
dyneins. Cytoplasmic dyneins are involved in a wide
range of intracellular functions, including chromosome
movements on the mitotic spindle and the transport of
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membranous organelles toward the minus ends of mi-
crotubules (Holzbaur and Vallee 1994). Axonemal dy-
neins are found in ciliary and flagellar axonemes. The
axonemal ultrastructure, which is highly conserved
through evolution, is composed of nine outer-doublet
microtubules that surround a central pair of singlet mi-
crotubules. Two dynein arms—outer and inner—are
bound to each peripheral microtubule doublet; these dy-
nein arms are essential for ciliary and flagellar beating,
which they generate through ATP-dependent cycles of
attachment/detachment to the adjacent microtubule
doublet (Witman 1992; Shingyoji et al. 1998).
Detailed structural and biochemical studies of dy-
nein arms have been performed in various species,
including sea urchins and Chlamydomonas rein-
hardtii, a unicellular alga with two flagella contain-
ing an axonemal structure similar to that of human
respiratory cilia and sperm tails (Blair and Dutcher
1992; Vallee 1993; Porter 1996). Such studies have
revealed that, depending on the species, the outer
dynein arms are composed of either two or three
heavy chains (Mr 1400,000), two to four interme-
diate chains (Mr 45,000–110,000), and several light
chains (Mr !30,000) (Porter 1996). Numerous genes
encoding dynein heavy and light chains have been
identified in various species (Gibbons et al. 1991;
Mitchell and Kang 1991; Ogawa 1991; Asai et al.
1994; Gibbons et al. 1994; Rasmusson et al. 1994;
Wilkerson et al. 1994; LeDizet and Piperno 1995b;
Tanaka et al. 1995; Andrews et al. 1996; Porter et
al. 1996; Vaughan et al. 1996; Neesen et al. 1997),
including humans (Milisav et al. 1996; Vaughan et
al. 1996; Chapelin et al. 1997b; Kastury et al. 1997;
Neesen et al. 1997). However, to date, genes encod-
ing intermediate chains belonging to the outer arms
have been identified only in Chlamydomonas (IC69
[GenBank accession number X55382] and IC78
[GenBank accession number U19120]) (Mitchell and
Kang 1991; Wilkerson et al. 1995) and in sea urchins
(IC1 [GenBank accession number D63884], IC2
[GenBank accession number D38538], and IC3
[GenBank accession number D28863]) (Ogawa et al.
1995, 1996) but not in humans.
Given the high complexity of the structures in-
volved in ciliary movements, the genetic heterogeneity
underlying PCD is expected to be extremely impor-
tant. Such a complexity may account for the failure
to establish a reproducible linkage between the PCD
phenotype and a genetic region (Chapelin et al.
1997a). Strikingly, several immotile strains of Chla-
mydomonas have been found to carry axonemal ul-
trastructural defects that are reminiscent of those re-
ported in patients with PCD (Mitchell and Kang 1991;
Sakakibara et al. 1991, 1993; Porter et al. 1994;
LeDizet and Piperno 1995a; Rupp et al. 1996; Myster
et al. 1997; Perrone et al. 1998). Among them, the
Chlamydomonas flagellar mutants carrying a defect
in IC78, a gene of relatively small size compared with
dynein heavy-chain genes, have been the subject of
detailed functional, ultrastructural, and molecular
studies (Wilkerson et al. 1995). Of particular interest,
the flagellar ultrastructural phenotype of these latter
mutants is similar to the axonemal ultrastructural ab-
normality (i.e., absence of outer dynein arms) ob-
served in several patients with PCD; we therefore de-
signed a strategy, on the basis of evolutionary
conservation of both the axonemal ultrastructure and
the genes encoding axonemal proteins, to isolate a




A 9-year-old boy (patient II-1), who was born to un-
related parents (family 1), presented in early childhood
with chronic respiratory symptoms characterized by
chronic sinusitis, serous otitis, and recurrent episodes of
bronchitis associated with severe segmental atelectasis
that had led to partial lobectomy. Chest radiography
showed normal cardiac and visceral situs. Neither his
parents nor his other relatives have a history of respi-
ratory disease. At the time of bronchoscopy, samples of
trachea mucosa were obtained and were processed for
ciliary studies, as described elsewhere (Escudier et al.
1990). No ciliary beating was observed, and transmis-
sion electron microscopy showed the absence of outer
dynein arms in all cilia, thereby confirming the diagnosis
of PCD. Five other unrelated consanguineous families
with PCD were also investigated (families 2–6). In two
independent families (families 2 and 3), the ultrastruc-
tural phenotype was identical to that documented in
patient II-1 from family 1; however, in one case (family
3), the patients with PCD also displayed situs inversus.
In the three remaining families (families 4–6), both outer
and inner dynein arms were absent in the patients’ cilia;
in one case (family 6), the disease phenotype was as-
sociated with situs inversus. In all these individuals,
DNA samples were isolated from peripheral-blood sam-
ples, according to standard techniques.
Cloning and Sequencing of Human DNAI1 cDNA and
Genomic DNA
To isolate a human gene homologous to the Chla-
mydomonas IC78 gene and the sea urchin IC2 gene, we
performed an alignment of the amino acid sequences of
IC2 and IC78, using the Clustal W1.7 program, and we
designed three degenerated primers (P1–P3) for PCR in
the most conserved regions of these two chains. The
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primers were used in reverse transcriptase–PCR (RT-
PCR) assays, with total RNA from human adult testis
and trachea used as templates (Clontech). PCR per-
formed with primers P1 (antisense) and P2 (sense) led
to the characterization of a 975-bp fragment of the hu-
man dynein axonemal intermediate chain–1 (DNAI1)
coding sequence. A specific primer (P10, sense) designed
in the new sequence was used with primer P3 (antisense)
in a PCR assay that gave rise to an additional DNAI1
cDNA fragment. On the basis of the latter sequence,
both the 5′ and 3′ portions of the human DNAI1 cDNA
sequence were obtained, by rapid amplification of cDNA
ends (RACE), with the use of Marathon-ready cDNA
from human testis (Clontech). The full-length coding
sequence of DNAI1 was subsequently amplified on total
trachea and testis RNAs, by means of RT-PCR with
primers P4 (forward) and P5 (reverse).
To characterize the intron-exon organization of the
DNAI1 gene, long-range PCRs were performed on hu-
man genomic DNA, by use of the Expand Long Tem-
plate PCR System kit (Boehringer Mannheim) and var-
ious sets of exonic primers designed in the human
DNAI1 cDNA, according to the manufacturer’s instruc-
tions. PCR products were purified with the use of the
PCR purification kit (Boehringer Mannheim) prior to
sequencing. All sequences were determined on both
strands.
Sequence Analysis, Alignment, and Construction of
Phylogenetic Tree
DNA homology searches were performed by use of
BLAST. Deduced amino acid sequences of Chlamydo-
monas IC78, sea urchin IC2, and the newly identified
human sequence, DNAI1, were multiply aligned with
the use of the ClustalW program, version 1.8 (Thomp-
son et al. 1994). The GCG PILEUP program was used
to generate relationship trees, on the basis of the neigh-
bor-joining method (Saitou and Nei 1987).
Northern Blot Analysis
For expression pattern analysis, two human mul-
tiple-tissue northern blot membranes were purchased
(Clontech). Four probes were obtained by PCR. These
probes recognize different cDNA regions defined by
positions 77 to 2241, 47 to 490, 848–2204,
and 2035–2241, respectively. Membranes were hy-
bridized with these probes, according to the manu-
facturer’s recommended protocol.
Mapping of the DNAI1 Gene
The chromosomal localization of the human DNAI1
gene was first determined by the screening of a panel of
24 hybrid somatic cell lines (human/rodent), by use of
PCR with DNAI1-specific primers (Quantum). PCR was
performed, as described above, with primers P12 (intron
17, sense) and P13 (intron 18, antisense). Further lo-
calization of the genomic DNAI1 probe was performed
on human metaphase chromosomes, by use of FISH
combined with R-banding, as described elsewhere (Lem-
ieux et al. 1992). The probe consisted of four genomic
DNA products amplified by PCR and covering 33.5 kb
of the DNAI1 gene. The probe labeled with biotin by
means of nick-translation (Pinkel et al. 1986) was vi-
sualized with fluorescein isothiocyanate (FITC)–avidin,
and the chromosomes were counterstained with 4,6-
diamidino-2-phenylindole. The specific signal intensity
and its sublocalization along the chromosome axis were
analyzed with use of the Cytogen Fluoquant program
(Imstar).
SSCP Mutation Analysis
DNAI1 exons were amplified with intronic primers
(available on request). PCR products were electro-
phoresed inmutation-detection–enhancement gel (Bio-
probe), with the use of 0.6#Tris-borate EDTA (TBE)
buffer at 4–10 W (depending on the size of each frag-
ment), for 16 h at room temperature. When bandshifts
were identified, the corresponding PCR products were
sequenced.
Characterization of DNAI1 Mutations
We used the following primers to amplify the genomic
DNA spanning the two mutated sites described in family
1: primers P6 (exon 1, sense) and P11 (intron 1, anti-
sense), which bracket the paternal mutation, were used
to amplify a 159-bp product in control subjects; primers
P8 (intron 4, sense) and P9 (intron 5, antisense), which
bracket the maternal mutation, were used to amplify a
276-bp product in control subjects. To determine the
consequences of the paternal mutation on the processing
of DNAI1 primary transcript, total RNA obtained from
both the patient and a control were prepared from nasal
brushing, according to standard procedures (Escudier et
al. 1990); RT-PCR was performed with exonic primers
P6 and P7 (exon 4, antisense).
Results
Isolation of the Human cDNA and Gene Encoding
DNAI1, a Protein Related to Chlamydomonas
reinhardtii Dynein IC78
To isolate the human cDNA sequence encoding
DNAI1 (dynein axonemal intermediate chain–1), we
used testis cDNAs as templates in cross-species PCR as-
says, with degenerated primers (P1–P3; see the Subjects
and Methods section, above) chosen from IC78 and IC2,
two orthologous cDNA sequences encoding an axone-
mal dynein intermediate chain in Chlamydomonas rein-
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hardtii and sea urchins, respectively. This gave rise to
PCR products that were cloned and sequenced, thereby
providing specific sequence information that was used
to perform 5′ and 3′ RACE experiments on human testis
cDNA. This procedure led to the characterization of the
2,526-bp full-length human DNAI1 coding sequence to-
gether with parts of the 5′ and 3′ untranslated regions
(UTR). This coding sequence was further confirmed by
the sequence determination of the RT-PCR products gen-
erated from trachea and testis RNAs, with the use of
two primers (P4 and P5) that bracket the full-length
coding region. The 5′-UTR sequence, which contains two
in-frame termination codons, includes 171 bp upstream
of the translation start. The isolated 3′-UTR sequence
(258 bp) contains a single putative polyadenylation sig-
nal (AATAAA) at position 2307 (nucleotide 1 corre-
sponds to A of the ATG translation start codon), located
207 bp downstream of the stop codon. The predicted
protein consists of 699 amino acids (fig. 1A). To better
characterize the DNAI1 cDNA, we integrated its cor-
responding amino acid sequence into an evolutionary
approach by constructing a phylogenetic tree with the
sequences of all outer arm dynein intermediate chains
identified to date and with several cytoplasmic inter-
mediate chains (fig. 2). The results of this analysis re-
vealed that DNAI1 exhibits less conservation with
DNCI1, the human cytoplasmic dynein intermediate
chain (15% identity), than with axonemal intermediate
chains from distantly related species (fig. 2). DNAI1 had
a greater similarity with sea urchin IC2 and Chlamy-
domonas IC78 sequences than with sea urchin IC3 and
Chlamydomonas IC69, which are two other closely re-
lated sequences; the deduced amino acid sequence of
human DNAI1 indeed displayed a significant homology
to IC2 and IC78 (probability values calculated by
BLAST: and , respec-272 187P = 1.2# 10 P = 3.1# 10
tively), with an overall sequence identity of 59% and
39% with IC2 and IC78, respectively. Regions of high
similarity are located in the carboxy-terminal halves of
these chains and primarily correspond to sequence ele-
ments known as tryptophan-aspartate (WD) repeats (fig.
1A). Five of the six WD consensus sequences present in
the Chlamydomonas IC78 sequence (Wilkerson et al.
1995) are conserved in sea urchin IC2 (Ogawa et al.
1995) and in human DNAI1 sequences. The five human
WD repeats share 29%–63% identity with the Chla-
mydomonas sequence and 51%–87% identity with the
sea urchin sequence.
Expression studies of DNAI1 provided additional ev-
idence that this cDNA indeed encodes an axonemal pro-
tein. Hybridization of the full-length DNAI1 cDNA
probe to commercially available multiple-tissue northern
blots revealed the presence of a specific and abundant
transcript of ∼2.5 kb in adult trachea and testis but not
in other adult tissues examined, which are devoid of cilia
(fig. 3). In trachea, an additional weakly expressed tran-
script of ∼4 kb was also detected. To determine whether
the 2.5-kb and 4-kb transcripts result from common
DNAI1 primary transcripts, we used four different
probes consisting of different parts of the cDNA in sim-
ilar northern blot experiments. All four probes recog-
nized the two transcripts (data not shown), in keeping
with a common origin of these two molecular species.
Genomic structure of the DNAI1 coding region was
elucidated by long-range PCRs between exons. The hu-
man DNAI1 gene (fig. 1B) is composed of at least 20
exons and 19 introns. All exons and introns were sized,
with each intron-exon boundary containing the gt-ag
consensus sequences for eukaryotic splice donor and ac-
ceptor sites.
Chromosomal Localization of the Human DNAI1
Gene
A primer set was used for PCR screening of a panel
of 24 hybrid somatic cell lines (human/rodent), each of
which retained 1 of the 24 human chromosomes. An
amplification product of expected size and sequence was
detected in only one hybrid cell line, demonstrating the
location of the human DNAI1 gene on chromosome 9
(data not shown). The gene was sublocalized by FISH.
Spots of specific hybridization were observed on meta-
phase spreads at band p13-21 (fig. 4).
DNAI1 Mutation Analysis
Patient II-1 from family 1 displayed a PCD phenotype
characterized by an absence of outer dynein arms (fig.
5). All the coding regions and intron-exon boundaries
of the DNA sample from this patient were amplified with
DNAI1-specific primers and were run on SSCP gels or
were sequenced directly. Two SSCP variants were iden-
tified in his genomic DNA; these variants were located
in two PCR fragments spanning exon 5 (fig. 6A) and
exon 1 (fig. 7A), respectively. Direct sequencing of these
amplified products yielded blurred sequencing patterns
(data not shown), a result suggesting the presence of
heterozygous insertions or deletions.
To characterize these molecular variations, we
cloned the corresponding PCR products. A 4-bp in-
sertion was present in 10 of the 20 clones spanning
exon 5 (fig. 6B). This short insertion, located at codon
95, resulted in the introduction of a VspI site, which
was used to confirm the maternal origin of the mu-
tated allele (fig. 6C). A similar experimental approach
led to the identification of a 1-bp insertion in the exon
1–amplified product; this mutation, which involves
the splice-donor site following exon 1, results in the
introduction of a HpaI site (fig. 7B). HpaI digestion
of the PCR-amplified genomic DNA spanning the mu-
tation site showed that the 1-bp insertion was inher-
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Figure 1 Predicted amino acid sequence and genomic organization of the human DNAI1 gene. A, Comparison of deduced amino acid
sequences of human DNAI1, sea urchin IC2, and Chlamydomonas IC78. Identical residues are denoted by a blackened background, whereas
similar residues are shaded. The five WD repeats are within boxes. Gaps that were introduced to optimize the alignment are denoted by dashes.
B, Intron-exon organization of the human DNAI1 gene. The 20 exons (E1–E20) encoding the DNAI1 protein are indicated by unshaded or
shaded boxes (translated and untranslated regions, respectively). The locations of the ATG initiating codon, the stop codon, and the poly-
adenylation signal are shown. The number of the first codon in each exon is indicated; exons beginning with the second or third base of a
codon are indicated by subscript 2 or 3, respectively. The exons are drawn to scale. Intron-exon boundaries are denoted by blackened triangles;
the size (kb) of each intron (I1–I19) is indicated at the bottom.
ited from the father (fig. 7C). The patient therefore
carries two different DNAI1 mutations, thereby dem-
onstrating compound heterozygosity, a finding that is
in keeping with the absence of consanguinity docu-
mented in this family.
The maternal 4-bp insertion results in a frameshift
leading to a premature stop codon 24 amino acids down-
stream. To determine the consequences of the paternally-
inherited splice-donor-site mutation on the processing of
DNAI1 transcripts, total RNA obtained from the nasal
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Figure 2 The deduced amino acid sequence of human DNAI1
(arrow) integrated into an evolutionary tree of representative classes
of dynein intermediate chains (IC): axonemal outer dynein IC and
cytoplasmic dynein IC subfamilies. A parsimony tree for Chlamydo-
monas IC78 and IC69, sea urchin IC2 and IC3, rat IC74 (GenBank
accession number X66845), rat dynein cytoplasmic intermediate
chain–2A (IC2A [GenBank accession number U39044]), mouse Dnci1
(GenBank accession number AF063229) and Dnci2 (GenBank acces-
sion number AF063231), Drosophila Cdic (GenBank accession num-
ber AF070687), Dictyostelium cytoplasmic dynein intermediate chain
(dicA [GenBank accession number U25116]), human DNCI1
(GenBank accession number AF063228), and the newly identified hu-
man DNAI1 was created by the PILEUP program.
Figure 3 Expression analysis of the human DNAI1 gene. North-
ern blot analysis was performed with the use of human multiple-tissue
northern blots (Clontech) hybridized with the full-length coding se-
quence of DNAI1 (top). A 2.5-kb transcript was detected in trachea
and testis tissues. An additional transcript of ∼4 kb was detected in
trachea tissue only. Probing with b-actin used as a control (resulting
in bands at 2.0 kb and 1.8 kb) is shown (bottom).
epithelial cells of patient II-1 was reverse-transcribed.
The resulting products were used as templates in a PCR
assay performed with DNAI1-specific primers bracket-
ing the splice junction (primers P6 and P7, located in
exon 1 and 4, respectively) (fig. 7D). Two molecular
species were generated: one of expected size (290 bp)
and a 422-bp fragment, which was observed only in the
patient’s sample and not that of the control. Sequencing
of these 290-bp and 422-bp PCR products revealed that
the larger fragment contained a 132-bp insertion cor-
responding to the 5′ intronic sequence following exon
1, thereby indicating a cryptic splice-donor site in this
intron at position 133 (fig. 7E). In addition, the same
RNA sample from patient II-1 was subjected to RT-PCR
with primers (P4 and P5) that bracket the full-length
DNAI1 coding sequence. The resulting PCR products
were cloned and sequenced. Among 36 clones analyzed,
22 were found to carry the paternally inherited 132-bp
insertion, whereas the 14 remaining clones contained the
maternal mutation.
To further test whether these two mutations are re-
sponsible for the PCD phenotype, 50 unrelated control
subjects were screened for these DNAI1 variations.
None of their 100 chromosomes contained such muta-
tions. However, in the course of this study, we identified
two intragenic nucleotide polymorphisms. One is lo-
cated at nucleotide 42 (GrC) of intron 11, and the other
one is a GrA transition at nucleotide 1003 that results
in the V335I substitution.
Locus Heterogeneity in PCD
The two intragenic polymorphisms were used to test
the involvement of DNAI1 in the PCD phenotype iden-
tified in five additional unrelated families (families 2–6),
in which the patients were born to consanguineous un-
ions. The genotype at these two loci was characterized
by genomic DNA sequencing. In family 2, the two af-
fected children, who displayed an absence of outer dy-
nein arms in all cilia, and the healthy older sister share
the same DNAI1 genotype, thereby demonstrating an
exclusion of linkage between the DNAI1 gene and the
PCD phenotype. In family 5, the two affected children,
who displayed a PCD phenotype characterized by an
absence of both outer and inner dynein arms, carried
different DNAI1 genotypes at nucleotide 42 of intron
11. In the three remaining consanguineous families (fam-
ilies 3, 4, and 6), the patients were found to be hetero-
zygous at one or both intragenic loci (data not shown).
Discussion
We have isolated a novel mammalian gene, named
DNAI1, which is predicted to encode a protein related
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Figure 4 Chromosomal mapping of the human DNAI1 gene. A, FISH showing localization of hybridization signals to both chromosomes
9 on metaphase spread (arrowheads). B, Magnification of chromosome 9 that allows the precise mapping of the DNAI1 gene to the p13-p21
region on both chromatids. C, Ideogram of human chromosome 9 that shows the precise localization of the DNAI1 gene (red arrowhead).
Figure 5 Electron micrograph of cross-sections of respiratory
cilia (original magnification #90,000). A, Absence of outer dynein
arms (arrow) is observed on all the peripheral doublets of the ciliary
sections obtained from PCD patient II-1. B, Normal ciliary ultras-
tructure from a control subject.
to a C. reinhardtii intermediate chain of dynein. We have
demonstrated its involvement in human PCD, an as-yet-
unexplained syndrome characterized by a severe respi-
ratory disease associated with male infertility. This gene,
which is highly expressed in trachea and testis, is com-
posed of 20 exons located in the p13-p21 region of chro-
mosome 9.
Several lines of evidence support the hypothesis that
DNAI1 encodes an axonemal intermediate chain of dy-
nein. First, BLAST analysis of the DNAI1 cDNA se-
quence revealed that its product was highly homologous
to sea urchin IC2 and Chlamydomonas IC78 sequences.
At least two subclasses of axonemal intermediate chains
of dynein have been identified in lower eukaryotic or-
ganisms: Chlamydomonas IC78 and sea urchin IC2 pro-
teins define one subclass, whereasChlamydomonas IC69
and sea urchin IC3 proteins belong to the second sub-
class of intermediate chains (Ogawa et al. 1995). On the
basis of the results of sequence analysis, DNAI1 is likely
to belong to the IC78/IC2 subclass of axonemal inter-
mediate chains; such a conclusion is further supported
by the following phylogenetic data: when compared with
axonemal intermediate chains and cytoplasmic inter-
mediate chains isolated in different species (Paschal et
al. 1992; Nurminsky et al. 1998; Crackower et al. 1999),
including the human DNCI1 chain (Crackower et al.
1999), DNAI1 is still closer to both Chlamydomonas
IC78 and sea urchin IC2. Second, the predicted protein
sequence (699 residues) contains several short motifs
known as “WD repeats,” which are highly conserved
through evolution among all axonemal intermediate
chains identified to date (Ogawa et al. 1995; Wilkerson
et al. 1995; Yang and Sale 1998). These motifs, which
are located in the carboxy-terminal halves of the inter-
mediate chains (Ogawa et al. 1995; Wilkerson et al.
1995), are thought to be involved in protein-protein in-
teractions within multicomponent complexes (Neer et
al. 1994; Smith et al. 1999). Third, the full-length
DNAI1 cDNA sequence, which was used as a probe on
northern blots with various human adult tissues, re-
vealed a signal only in testis and trachea; since these two
tissues contain numerous axonemal structures, such hy-
bridization data further support the hypothesis that the
identified sequence indeed encodes an axonemal protein.
A major transcript (∼2.5 kb) was found in both tissues,
whereas an additional weakly expressed transcript (∼4
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Figure 6 The exonic insertion identified on the maternal DNAI1 allele of patient II-1 from family 1. A, SSCP analysis of the PCR products
of exon 5 from three members (I-1, I-2, and II-1) of this family and from a control subject (N), showing bandshifts (arrows) both in patient
II-1, who is denoted by a blackened square, and in his mother (I-2). Lane C corresponds to a negative control (PCR without genomic DNA).
B, Nucleotide sequence of the mutant (top) and normal (bottom) DNAI1 alleles. The insertion of four nucleotides in exon 5 is denoted by the
area outlined by a solid line. The recognition sequence for the VspI restriction endonuclease is denoted by the area outlined by a dashed line.
C, Segregation analysis of the 4-bp insertion within the family. The presence of the mutation in the genomic DNA from all three family members
was assessed by VspI digestion of PCR products generated with primers P8 and P9. The affected child (II-1) and his mother (I-2) yield a banding
pattern consistent with the presence of both the normal (276-bp) and the mutant (80-bp and 200-bp) alleles, whereas both his father (I-1) and
a control subject (N) display only normal alleles. Lane C corresponds to a negative control (PCR without genomic DNA). The size marker (M)
is a 1-kb ladder from Gibco BRL.
kb) was visualized only in trachea tissue. This latter mo-
lecular species, which was detected with different probes
covering either the 5′ part or the 3′ part of the cloned
cDNA, is highly likely to correspond to a DNAI1 tran-
script with a larger 3′ UTR resulting from the use of a
second polyadenylation site.
We postulated that the human DNAI1 gene identified
in this study was an excellent candidate sequence for
investigation in patients with a PCD phenotype char-
acterized by an absence of outer dynein arms. Chla-
mydomonas IC78 indeed belongs to outer dynein arms
(King et al. 1991; Wilkerson et al. 1995); its sequence
similarity with DNAI1 therefore suggests that, in hu-
mans, the DNAI1 protein may also participate in the
composition of outer dynein arms. In addition, in Chla-
mydomonas, protein cross-linking studies indicated that
IC78 is in direct contact with a-tubulin in the axoneme
(King et al. 1991, 1995), thereby suggesting that IC78
may be involved in anchoring the outer arm to the pe-
ripheral microtubules. Furthermore, a lack of outer dy-
nein arms has been clearly documented in the axonemes
of Chlamydomonas strains, in which the IC78 gene is
either deleted or disrupted by a large insertion (Wilk-
erson et al. 1995). Two different transallelic germline
DNAI1 mutations leading to frameshifts were indeed
identified in one patient presenting with a PCD phe-
notype associated with an absence of outer dynein arms.
The 4-bp insertion identified on the maternal DNAI1
allele, which probably arose as a result of slippage rep-
lication, is predicted to produce a frameshift introducing
a premature stop codon located 24 amino acids down-
stream. The paternal mutation is a splice defect; if trans-
lated, the abnormal DNAI1 transcript, which retains the
first 132 nucleotides of intron 1, would result in a pre-
mature TGA stop codon at position 73. Both the ma-
ternal mutation and the paternal mutation should, there-
fore, generate severely truncated polypeptides lacking
85% and 95%, respectively, of the DNAI1 protein, with
Figure 7 The splice mutation identified on the paternal DNAI1 allele of patient II-1 from family 1. A, SSCP analysis of the PCR products
of exon 1, which were obtained from three members of this family and from a control subject (N), show bandshifts (arrows) both in patient
II-1 (denoted by the blackened square) and in his father (I-1). Lane C corresponds to a negative control (PCR without genomic DNA). B,
Nucleotide sequence of the mutant (top) and normal (bottom) DNAI1 alleles. The 1-bp insertion (T) at nucleotide 3 of the intronic sequence
following exon 1 is outlined by a solid line. The recognition sequence for the HpaI restriction endonuclease is denoted by the area outlined by
a dashed line, and the position of the exon-intron boundary is indicated above the sequence. C, Segregation analysis of the 1-bp insertion within
the family. The presence of the mutation in the genomic DNA from all three family members was assessed by HpaI digestion of PCR products
generated with primers P6 and P11. The affected child (II-1) and his father (I-1) yield a banding pattern consistent with the presence of both
normal (159-bp) and mutant (97-bp and 63-bp) alleles, whereas both his mother (I-2) and a control subject (N) display only the normal alleles.
Lane C corresponds to a negative control sample (PCR without genomic DNA). The size marker (M) is a 1-kb ladder from Gibco BRL. D,
Functional consequences of this 1-bp insertion on DNAI1 RNA splicing. RT-PCR amplifications of total RNA obtained from nasal cells from
a control subject (lane N) and from the patient (lane II-1), with the use of primers P6 and P7. The RNA sample from the control subject
generates a 290-bp product, whereas the RNA sample from patient II-1 generates two products, one of normal size (290 bp) and one arising
from abnormal splicing (422 bp). Lane C contains a control without RNA sample. The size marker (lane M) is a 1-kb ladder from Gibco BRL.
E, Schematic representations of the splicing mechanisms leading to normal (top) and abnormal (bottom) DNAI1 transcripts, from the corre-
sponding genomic DNA fragments (middle). The 1-bp insertion at the third nucleotide of intron 1 is indicated below the genomic sequence
(arrowhead). Exonic sequences (E1–E4) and intronic sequences are denoted by gray boxes and thick solid lines, respectively. In the intronic
sequence following exon 1, lowercase letters indicate the 5′ splice consensus site normally used in primary DNAI1 transcripts; letter D denotes
the cryptic splice-donor site used in the presence of the 1-bp insertion. The sizes of the normal (top) and mutant (bottom) RT-PCR products
generated with primers P6 and P7 (arrows) are indicated. In the presence of the 1-bp insertion (asterisk), the 5′ part of the intron (open box)
following exon 1 is retained in the mutant cDNA (bottom).
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these large deleted regions including all five WD repeat
motifs. Taken together, these data strongly suggest that
such truncated proteins, even if synthesized, could not
play their key role in the outer dynein arm assembly. We
therefore conclude that these mutations, which were ab-
sent from 100 control chromosomes, underlie the ultra-
structural phenotype observed in this patient with PCD.
The documented immotile cilia are also consistent with
the absence of outer dynein arms; this may be respon-
sible for the mucociliary impairment that has led to the
severe chronic respiratory symptoms observed in this
patient.
In the course of this study, in addition to these two
disease-causing mutations, we have detected two nucle-
otide polymorphisms in DNAI1, a finding that has al-
lowed us to demonstrate an exclusion of linkage between
the DNAI1 gene and the PCD phenotype in five un-
related consanguineous families. These linkage data,
which provide the first clear-cut demonstration of locus
heterogeneity in this condition, also reveal a higher com-
plexity level of heterogeneity than was first expected,
since patients with identical ultrastructural defects may
have mutations in other as-yet-unidentified genes; it is
tempting to speculate that these latter genes may encode
functional partners of DNAI1 involved in dynein arm
assembly. Given the documented clinical, ultrastructural,
and genetic heterogeneity in PCD, it is, therefore, not
surprising that genetic analyses performed in different
sets of families did not allow establishment of repro-
ducible genetic linkage between the disease phenotype
and a given chromosomal region (Chapelin et al. 1997a;
Witt et al. 1999). However, in theory, this kind of ap-
proach could be fruitful, if applied to the study of sep-
arate families, with each being considered individually.
Nevertheless, such genetic linkage studies have been
hampered by the small size of affected families, in which
male patients are usually infertile. As shown in the pre-
sent study, this is the reason why approaches made on
the basis of the investigation of candidate genes represent
powerful alternatives. These candidate genes include the
dynein gene family; however, the great number and the
huge size of several of these genes make the ultrastruc-
tural phenotype the most pertinent feature for the iden-
tification of the best candidate(s). This study illustrates
the use of one particular Chlamydomonas flagellar mu-
tant as an excellent model for axonemal abnormalities
observed in PCD; as several other light (LeDizet and
Piperno 1995a), intermediate (Mitchell and Kang 1991;
Perrone et al. 1998), and heavy (Sakakibara et al. 1991;
Sakakibara et al. 1993; Porter et al. 1994; Rupp et al.
1996; Myster et al. 1997) chains of dynein have been
implicated in other Chlamydomonas flagellar mutants,
we consider the corresponding genes to be good can-
didates for other subsets of PCD and related develop-
mental diseases.
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